Patents by Inventor Peter A. Atlman

Peter A. Atlman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of preparing autologous cells and methods of use for therapy
    Patent number: 10035982
    Abstract: A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium which can be used in a clinical setting, and a business method for performing such expansions in the future as a service for patients. A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium including a diagnostic kit for the autologous cell therapy to determine whether a patient will respond to the autologous cell therapy for treatment of a disease, in which said kit comprising a system for detecting gene and protein expression comprising at least two isolated DNA molecules wherein each isolated DNA molecule detects expression of a gene that is differentially expressed in the tissue of the patient that is intended to be the source of the autologous cell therapy.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: July 31, 2018
    Assignee: BioCardia, Inc.
    Inventors: Didier Rouy, Peter A. Atlman, Benjamin Koziner
  • METHOD OF PREPARING AUTOLOGOUS CELLS AND METHODS OF USE FOR THERAPY
    Publication number: 20170327790
    Abstract: A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium which can be used in a clinical setting, and a business method for performing such expansions in the future as a service for patients. A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium including a diagnostic kit for the autologous cell therapy to determine whether a patient will respond to the autologous cell therapy for treatment of a disease, in which said kit comprising a system for detecting gene and protein expression comprising at least two isolated DNA molecules wherein each isolated DNA molecule detects expression of a gene that is differentially expressed in the tissue of the patient that is intended to be the source of the autologous cell therapy.
    Type: Application
    Filed: July 31, 2017
    Publication date: November 16, 2017
    Applicant: BioCardia, Inc.
    Inventors: Didier Rouy, Peter A. Atlman, Benjamin Koziner
  • Method of preparing autologous cells and methods of use for therapy
    Patent number: 9752123
    Abstract: A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium which can be used in a clinical setting, and a business method for performing such expansions in the future as a service for patients. A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium including a diagnostic kit for the autologous cell therapy to determine whether a patient will respond to the autologous cell therapy for treatment of a disease, in which said kit comprising a system for detecting gene and protein expression comprising at least two isolated DNA molecules wherein each isolated DNA molecule detects expression of a gene that is differentially expressed in the tissue of the patient that is intended to be the source of the autologous cell therapy.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: September 5, 2017
    Assignee: BioCardia, Inc.
    Inventors: Didier Rouy, Peter A. Atlman, Benjamin Koziner
  • METHOD OF PREPARING AUTOLOGOUS CELLS AND METHODS OF USE FOR THERAPY
    Publication number: 20160228469
    Abstract: A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium which can be used in a clinical setting, and a business method for performing such expansions in the future as a service for patients. A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium including a diagnostic kit for the autologous cell therapy to determine whether a patient will respond to the autologous cell therapy for treatment of a disease, in which said kit comprising a system for detecting gene and protein expression comprising at least two isolated DNA molecules wherein each isolated DNA molecule detects expression of a gene that is differentially expressed in the tissue of the patient that is intended to be the source of the autologous cell therapy.
    Type: Application
    Filed: February 26, 2016
    Publication date: August 11, 2016
    Inventors: Didier Rouy, Peter A. Atlman, Benjamin Koziner